ppt good clinical practice

good clinical practice mention about the goal working and the princple

1. R.C patel institute of pharmaceutical,
education and research,shirpur.
Topic:-Good clinical practice
Prepared By:Siddhesh Sanghavi
Class: FY Mpharm
Guided By:Dr. Pankaj Nerker Sir
R.c patel Institute Of Pharmaceutical And Research
Centre,Shirpur.
1

2. Good clinical practice
2

3. Definition Of GCP
•Good Clinical Practice (GCP) is an international
ethical and scientific quality standard for the design,
conduct, performance, monitoring, auditing,
recording, analyses and reporting of clinical trials.
GCP provides assurance that the data and reported
results are credible and accurate, and that the rights,
integrity and confidentiality of trial subjects are
respected and protected.
3

4. Purpose Of GCP
TO harmonize the
regulation and guidelines
for the drug development
4

5. participants
Regulatory agencies/industry
Representatives from europe,
japan, and US
5

6. Goal
•To remove redudancy/duplication in
development of the review process.
•For new medical product, the data should
demonstrate:
Safety Quality
Efficacy
6

7. Process
•The developed guidelines were applicable for:

•Approved by ICH members
•Adopted by the National Regulatory
Authorities
drugs
biologics
Medical device
7

8. Background history

8

9. 9

10. 10

11. 11

12. Principle Of ICH GCP
•Ethics
•Clinical trials should be conducted in accordance with the ethical principles
that have their origin in the Declaration of Helsinki, and that are consistent
with GCP and the applicable regulatory requirement(s).
•Trial risk vs trial benefit
•Before a trial is initiated, foreseeable risks and inconveniences should be
weighed against the anticipated benefit for the individual trial subject and
society. A trial should be initiated and continued only if the anticipated
benefits justify the risks.
•Trial participants
•The rights, safety, and well-being of the trial subjects are the most
important considerations and should prevail over interests of science and
society.
12

13. •Information on the Medicinal Product
•The available non-clinical and clinical information on an investigational
Product should be adequate to support the proposed clinical trial
•Good quality trials
•Clinical trials should be scientifically sound, and described a clear detailed
protocol
•Compliance with the study protocol
•A trial should be conducted in compliance with the protocol that has
received prior institutional review board (IRB) independent ethics
commitees (IEC)approval/favourable opinion.
13

14. •Medical decisions
•The medical care given to, and medical decisions made on behalf of,
subjects should always be the responsibility of a qualified physician or,
when appropriate, of a qualified dentist.
•Trial staff
•Each individual involved in conducting a trial should be qualified by
education, training, and experience to perform his or her respective task(s).
•Informed consent
Freely given informed consent should be obtained from every subject prior
to clinical trial participation.
14

15. •Clinical trial data
•All clinical trial information should be recorded, handled, and stored in a
way that allows its accurate reporting, interpretation and verification.
•Confidentiality
•The confidentiality of records that could identify subjects should be
protected, respecting the privacy and confidentiality rules in accordance
with the applicable regulatory requirement(s).
•Good Manufacturing Practice
•Investigational products should be manufactured, handled, and stored in
accordance with applicable good manufacturing practice (GMP). They
should be used in accordance with the approved protocol.
15

16. •Quality assurance
•Systems with procedures that assure the quality of every aspect of the trial
should be implemented.
16